Effect of Varenicline on Tardive Dyskinesia: A Pilot Study

OBJECTIVE: Although evidence implicates striatal cholinergic impairment as a mechanism underlying tardive dyskinesia, trials of nonspecific cholinergic agents have been inconclusive. As a partial agonist at specific nicotinic receptor subtypes, varenicline reduces drug-induced dyskinesias in animal...

Descripción completa

Detalles Bibliográficos
Autores principales: Caroff, Stanley N., Gutman, Alisa R., Northrop, John, Leong, Shirley H., Berkowitz, Rosalind M., Campbell, E. Cabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077061/
https://www.ncbi.nlm.nih.gov/pubmed/33888664
http://dx.doi.org/10.9758/cpn.2021.19.2.355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077061/
https://www.ncbi.nlm.nih.gov/pubmed/33888664
http://dx.doi.org/10.9758/cpn.2021.19.2.355

Ejemplares similares